These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36102633)

  • 1. Genomic profile of TdT
    Hamdan H; Luu L; Opsahl M; Weinberg O; Fuda F; Koduru P; Wilson K; Gagan J; Ramakrishnan Geethakumari P; Collins R; Chen W
    Cytometry B Clin Cytom; 2022 Nov; 102(6):448-450. PubMed ID: 36102633
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous involvement of high-grade B-cell lymphoma with MYC and BCL6 rearrangements: A case report.
    Maejima E; Oishi N; Ogawa Y; Okamoto T; Mitsui H; Shimada S; Kawamura T
    J Dermatol; 2023 Aug; 50(8):e243-e244. PubMed ID: 36890662
    [No Abstract]   [Full Text] [Related]  

  • 3. EBV-positive high-grade B-cell lymphoma with MYC and BCL6 rearrangements.
    Craig A; Wen KW
    Blood; 2022 Jul; 140(4):406. PubMed ID: 35900784
    [No Abstract]   [Full Text] [Related]  

  • 4. [B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].
    Luo DL; Liu YH; Zhang F; Xu FP; Yan LX; Chen J; Xu J; Luo XL; Zhuang HG
    Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):584-8. PubMed ID: 24314242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unexpected favorable outcome in a patient with high grade B-cell lymphoma with abnormalities of MYC, BCL6 and BCL2 loci.
    Adams T; Fuchs D; Shadoan PK; Johnstone L; Lau BM; McGhan L; Anwer F; Al-Kateb H
    Cancer Genet; 2018 Apr; 222-223():25-31. PubMed ID: 29666005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple hit B-cell lymphoma with diffuse kidney involvement sparing the glomeruli.
    Ali ND; Bains A
    Blood; 2019 Sep; 134(10):842. PubMed ID: 31488459
    [No Abstract]   [Full Text] [Related]  

  • 7. High-grade B-cell lymphoma with MYC and BCL2 rearrangements presenting as a cervical mass.
    Lin C; Kuma L; Shen L
    Pathology; 2024 Jun; 56(4):588-590. PubMed ID: 37940480
    [No Abstract]   [Full Text] [Related]  

  • 8. Triple-hit B-cell Lymphoma With MYC, BCL2, and BCL6 Translocations/Rearrangements: Clinicopathologic Features of 11 Cases.
    Wang W; Hu S; Lu X; Young KH; Medeiros LJ
    Am J Surg Pathol; 2015 Aug; 39(8):1132-9. PubMed ID: 25828391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma.
    Ye Q; Xu-Monette ZY; Tzankov A; Deng L; Wang X; Manyam GC; Visco C; Montes-Moreno S; Zhang L; Dybkær K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Parsons BM; Møller MB; Piris MA; Winter JN; Medeiros LJ; Hu S; Young KH
    Oncotarget; 2016 Jan; 7(3):2401-16. PubMed ID: 26573234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of translocations involving c-MYC/8q24, BCL2/18q21 and/or BCL6/3q27 genes in patients with follicular lymphoma. Retrospective analysis of single - centre data].
    Misyurina AE; Kravchenko SK; Kovrigina AM; Magomedova AU; Plastinina LV; Obukhova TN; Misyurin AV; Misyurin VA; Grebenuk LA; Babaeva FE; Baryakh EA; Vorobiev AI
    Ter Arkh; 2019 Jul; 91(7):52-62. PubMed ID: 32598736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Approach for Double-Hit and Triple-Hit Lymphoma Based on Immunophenotypic and Cytogenetic Characteristics of Bone Marrow Specimens.
    Kim H; Kim HJ; Kim SH
    Ann Lab Med; 2020 Sep; 40(5):361-369. PubMed ID: 32311849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of immunophenotype to the investigation and differential diagnosis of Burkitt lymphoma, double-hit high-grade B-cell lymphoma, and single-hit MYC-rearranged diffuse large B-cell lymphoma.
    Tsagarakis NJ; Papadhimitriou SI; Pavlidis D; Liapis K; Gortzolidis G; Kostopoulos IV; Marinakis T; Paterakis G
    Cytometry B Clin Cytom; 2020 Sep; 98(5):412-420. PubMed ID: 32497402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of 'double-hit' and 'double-expression' lymphomas.
    Ma Z; Niu J; Cao Y; Pang X; Cui W; Zhang W; Li X
    J Clin Pathol; 2020 Mar; 73(3):126-138. PubMed ID: 31615842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYC/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis.
    Li S; Desai P; Lin P; Yin CC; Tang G; Wang XJ; Konoplev SN; Khoury JD; Bueso-Ramos CE; Medeiros LJ
    Histopathology; 2016 Jun; 68(7):1090-8. PubMed ID: 26426741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of C-MYC in the spectrum of transformed follicular lymphoma grade 3b.
    Tzankov A; Höllrigl A; Verdorfer I; Oxle H
    Hum Pathol; 2007 Jan; 38(1):191-2; author reply 192-3. PubMed ID: 17169631
    [No Abstract]   [Full Text] [Related]  

  • 16. What does MYC, BCL2, and BCL6 genes 'rearranged' mean in large cell/diffuse B-cell lymphomas?
    Trombetta D; Zanelli M; Garuti A; Carosi I; Mastracci L; Ascani S; Graziano P; Parente P
    Pathol Res Pract; 2022 Dec; 240():154199. PubMed ID: 36368276
    [No Abstract]   [Full Text] [Related]  

  • 17. Low LIM-domain only 2 (LMO2) expression in aggressive B cell lymphoma correlates with
    Chapman J; Verdun RE; Lossos IS
    Leuk Lymphoma; 2021 Oct; 62(10):2547-2550. PubMed ID: 33988072
    [No Abstract]   [Full Text] [Related]  

  • 18. High-grade B-Cell Lymphoma With MYC, BCL2, and/or BCL6 Translocations/Rearrangements: Clinicopathologic Features of 51 Cases in a Single Institution of South China.
    Zhang J; Weng Z; Huang Y; Li M; Wang F; Wang Y; Rao H
    Am J Surg Pathol; 2020 Dec; 44(12):1602-1611. PubMed ID: 32991338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYC, BCL2, and BCL6 rearrangements in primary central nervous system lymphoma of large B cell type.
    Nosrati A; Monabati A; Sadeghipour A; Radmanesh F; Safaei A; Movahedinia S
    Ann Hematol; 2019 Jan; 98(1):169-173. PubMed ID: 30306208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis.
    Li S; Weiss VL; Wang XJ; Desai PA; Hu S; Yin CC; Tang G; Reddy NM; Medeiros LJ; Lin P
    Am J Surg Pathol; 2016 Feb; 40(2):253-61. PubMed ID: 26448193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.